Historical record - last NADAC effective date: 3/23/2022
Product Information
MUCINEX FAST-MAX COLD-FLU CAP is a brand product labeled by RB Health (US) LLC, priced at $0.7369 per EA under NDC 63824051816. Its NADAC has been published 141 times since Oct 23, 2019.
The High Outlier badge above means this manufacturer's average price in the ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
MUCINEX FAST-MAX COLD-FLU CAP
ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDEStrength
325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1
Manufacturer
RB Health (US) LLCNDC
63824051816
Classification
Brand
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
3/23/2022
Active Ingredients
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/28/2018
Pharmacological Classes
Price Statistics
The NADAC for MUCINEX FAST-MAX COLD-FLU CAP has been published 141 times since Oct 23, 2019, and over the history we have for it it has risen 7.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7369 per EA |
|---|---|
| All-time high | $0.7673 (Oct 13, 2021) |
| All-time low | $0.6867 (Oct 23, 2019) |
| Median price | $0.7132 |
| Average price | $0.7188 |
| Largest weekly change | -5.7% (Feb 23, 2022) |
| Weeks tracked | 141 |
| Tracking since | Oct 23, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+0.4%
All
+7.3%
Last surveyed Jun 29, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MUCINEX FAST-MAX COLD-FLU CAP?
The current National Average Drug Acquisition Cost (NADAC) for MUCINEX FAST-MAX COLD-FLU CAP, manufactured by RB Health (US) LLC, is $0.7369 per EA (NDC 63824051816), effective Jun 29, 2022.
How has the price of MUCINEX FAST-MAX COLD-FLU CAP changed over time?
Over the history we have for it, the NADAC for MUCINEX FAST-MAX COLD-FLU CAP has risen 7.3%. It has been tracked across 141 weekly CMS publications since Oct 23, 2019.
What are the highest and lowest recorded NADAC prices for MUCINEX FAST-MAX COLD-FLU CAP?
Since Oct 23, 2019, the NADAC for MUCINEX FAST-MAX COLD-FLU CAP has ranged from a low of $0.6867 (Oct 23, 2019) to a high of $0.7673 (Oct 13, 2021), with a median of $0.7132 per EA.
Are there cheaper alternatives to MUCINEX FAST-MAX COLD-FLU CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MUCINEX FAST-MAX COLD-FLU CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures MUCINEX FAST-MAX COLD-FLU CAP?
MUCINEX FAST-MAX COLD-FLU CAP (NDC 63824051816) is labeled by RB Health (US) LLC, and CMS classifies it as a brand product.